# Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation

> **NCT00805701** · PHASE4 · COMPLETED · sponsor: **Bay State Clinical Trials, Inc.** · enrollment: 40 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** avodart
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00805701
- **Lead sponsor:** Bay State Clinical Trials, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-05-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00805701

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00805701, "Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00805701. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*